Elite Pharmaceuticals Stock News

Elite Pharmaceuticals, Inc. (ELTP) Q3 2024 Earnings Call Transcript

Conference Call Scheduled for Thursday, February 15 at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / February 14, 2024 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCBB:ELTP), a specialty pha

Financials for Third Quarter Fiscal Year 2024 Ended December 31, 2023 will be released on February 14, 2024 NORTHVALE, NJ / ACCESSWIRE / February 8, 2024 / Elite Pharmaceuticals, Inc. ("Elite" or the

NORTHVALE, NJ / ACCESSWIRE / December 26, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP), a specialty pharmaceutical company engaged in the development, manufacture, and di

NORTHVALE, NJ / ACCESSWIRE / December 12, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announ

The equities market can feel like navigating through a fog while searching for the best penny stocks. Yet, amidst this uncertainty, a handful of names emerge as clear winners, displaying robust resili

Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q2 2024 Earnings Call Transcript November 15, 2023 11:30 AM ET Company Participants Nasrat Hakim - President and Chief Executive Officer Carter Ward - Chief Fi

Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone The U.S. Navy is looking to use the ZenaDrone 1000 for a variety of missions, including surveillance, search and rescue and reconnaissance. Miami, FL -- (InvestorsHub NewsWire - November 16, 2023) - EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on Epazz, Inc. (OTC Pink: EPAZ). &n...

Conference Call Scheduled for Wednesday, November 15 at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / November 14, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty p

Financials for Second Quarter Fiscal Year 2024 Ended September 30, 2023 will be released on November 14, 2023 NORTHVALE, NJ / ACCESSWIRE / November 10, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or t

Navigating the stock market's murky waters, the forecast for promising penny stocks might seem overcast. Within this realm, though, certain names are bucking the trend, boasting robust performances th

When it comes to stock predictions and penny stocks to buy, admittedly the near-term picture remains cloudy. Right now, it's unclear whether high interest rates, high inflation, and the still-present

NORTHVALE, NJ / ACCESSWIRE / September 25, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCQB:ELTP), a specialty pharmaceutical company engaged in the development, manufacture, and di

NORTHVALE, NJ / ACCESSWIRE / September 7, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic prod

“Penny stock territory” may be chock full of “fallen angels,” former high-fliers, along with shares in companies with minimal growth prospects, but among the thousands of publicly-traded stock